Efficacy and Safety of Sucroferric Oxyhydroxide and Calcium Carbonate in Hemodialysis Patients

INTRODUCTION: In this phase III, open-label, single-arm, multi-center 12-week study, we evaluated the efficacy and safety of combination therapy with sucroferric oxyhydroxide (PA21) and calcium carbonate for hemodialysis patients with hyperphosphatemia. METHODS: We enrolled 35 subjects aged ≥ 20 yea...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Kidney Int Rep
Main Authors: Koiwa, Fumihiko, Yokoyama, Keitaro, Fukagawa, Masafumi, Akizawa, Tadao
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2017
Assuntos:
Clinical Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5762971/
https://ncbi.nlm.nih.gov/pubmed/29340330
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2017.10.003
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares